Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Clearmind Medicine Inc (CMND)

Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Clearmind Medicine Inc 101-1220 WEST 6TH AVENUE VANCOUVER A1 V6H1A5 CAN

www.clearmindmedicine.com

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Clearmind Medicine Inc. is based in VANCOUVER.

Key Statistics

Overview:

Market Capitalization, $K 3,740
Enterprise Value, $K -2,830
Shares Outstanding, K 5,466
Annual Sales, $ 0 K
Annual Net Income, $ -5,250 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,310 K
EBIT, $ -5,810 K
EBITDA, $ -5,800 K
60-Month Beta 0.97
% of Institutional Shareholders 96.05%
Float, K 5,466
% Float 100.00%
Short Volume Ratio 0.38

Growth:

1-Year Return -51.13%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.25 on 09/11/25
Next Earnings Date 09/15/25
Earnings Per Share ttm -0.76
EPS Growth vs. Prev Qtr -56.25%
EPS Growth vs. Prev Year 57.63%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 11/28/23

CMND Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -173.87%
Return-on-Assets % -70.55%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.97
Book Value/Share 0.25
Interest Coverage -121.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar